RO 316840
Alternative Names: 2' BFddC; F DDC; Fluoro DDC; Fluoro-DDCYDLatest Information Update: 14 Nov 2006
At a glance
- Originator Roche
- Class Antiretrovirals; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B; HIV infections
Most Recent Events
- 29 Oct 1999 No-Development-Reported for Hepatitis B in USA (Unknown route)
- 29 Oct 1999 No-Development-Reported for HIV infections treatment in United Kingdom (Unknown route)
- 17 Nov 1994 Preclinical development for Hepatitis B in USA (Unknown route)